Compare AU

Compare CURE vs. MVR

Compare shares and ETFs on the ASX that you can trade on Pearler.

S&P US Biotech

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the S&P US Biotech (CURE) and the Aussie Large-Cap Resources (MVR). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.

Community Stats

CURE

MVR

Popularity

Low

Low

Pearlers invested

82

101

Median incremental investment

$619.50

$968.62

Median investment frequency

Monthly

Monthly

Median total investment

$1,325.00

$1,887.84

Average age group

> 35

> 35


Key Summary

CURE

MVR

Strategy

CURE.AX was created on 2018-11-08 by Global X. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index.

MVR.AX was created on 2013-10-14 by VanEck. The fund's investment portfolio concentrates primarily on theme equity. MVR.AX gives investors exposure to a diversified portfolio of ASX-listed securities with the aim of providing investment returns before fees and other costs which track the performance of the Index.

Top 3 holdings

Natera Inc (3.33 %)

Incyte Corp (2.95 %)

Gilead Sciences Inc (2.81 %)

Woodside Energy Group Ltd (7.66 %)

BHP Group Ltd (7.56 %)

Rio Tinto Ltd (7.00 %)

Top 3 industries

Health Care (100.00 %)

Other (10.24 %)

Materials (53.51 %)

Energy (22.01 %)

Utilities (9.59 %)

Top 3 countries

United States (97.17 %)

Switzerland (1.51 %)

United Kingdom of Great Britain and Northern Ireland (1.16 %)

Australia (95.51 %)

United States (4.49 %)

Management fee

0.45 %

0.35 %


Key Summary

CURE

MVR

Issuer

Global X

VanEck

Tracking index

S&P Biotechnology Select Industry

MVIS Australia Energy & Mining Index - AUD

Asset class

ETF

ETF

Management fee

0.45 %

0.35 %

Price

$50.00

$33.12

Size

$36.301 million

$435.041 million

10Y return

N/A

88.29 %

Annual distribution yield (5Y)

4.24 %

6.14 %

Market

ASX

ASX

First listed date

12/11/2018

16/10/2013

Purchase fee

$6.50

$6.50


Community Stats

CURE

MVR

Popularity

Low

Low

Pearlers invested

82

101

Median incremental investment

$619.50

$968.62

Median investment frequency

Monthly

Monthly

Median total investment

$1,325.00

$1,887.84

Average age group

> 35

> 35


Pros and Cons

CURE

MVR

Pros

  • Higher exposure to US market

  • Higher exposure to AU market

  • Lower management fee

  • Higher price growth

  • Higher distribution yield

Cons

  • Lower exposure to AU market

  • Higher management fee

  • Lower price growth

  • Lower distribution yield

  • Lower exposure to US market

CURE

MVR

Lower exposure to AU market

Higher exposure to AU market

Higher exposure to US market

Lower exposure to US market

Higher management fee

Lower management fee

Lower price growth

Higher price growth

Lower distribution yield

Higher distribution yield

Home